Skip to main content
Erschienen in: Rheumatology International 3/2024

27.08.2023 | Case Based Review

Coexistence of IgG4-related disease and ANCA-associated vasculitis: case report and review of the literature

verfasst von: Cengiz Korkmaz, Reşit Yıldırım, Mustafa Dinler, Döndü U. Cansu

Erschienen in: Rheumatology International | Ausgabe 3/2024

Einloggen, um Zugang zu erhalten

Abstract

IgG4-related disease (IgG4-RD) is a fibroinflammatory condition that is characterized by storiform fibrosis, infiltration of IgG4-positive lymphocytes, obliterative phlebitis, and high IgG4 levels. Since IgG4-RD affects a wide variety of organs, a differential diagnosis must include multiple conditions. IgG4-RD is also believed to coexist with certain diseases. In recent years, case reports and case series describing the co-occurrence of IgG4-RD and ANCA-associated vasculitis (AAV) have been published. We intended to evaluate patients with IgG4-RD and AAV overlap in the literature using a case similar to one that was diagnosed and monitored in our department. We searched the databases of Web of Science, Scopus, and Google Scholar as well as PubMed with the keywords ANCA, IgG4, IgG4-RD, granulomatosis with polyangiitis, Wegener’s granulomatosis, microscopic polyangiitis, Eosinophilic granulomatosis with polyangiitis, and Churg–Strauss syndrome. Cases and Case series addressing the coexistence of IgG4-RD and AAV have been selected. Comprehensive diagnostic criteria are used to diagnose IgG4-RD. The Chapel Hill Consensus Conference nomenclature criteria were used for the inclusion of AAV. Out of a total of 910 publications, 20 articles, including 65 cases, were found to be eligible. Forty-seven cases with IgG4-RD were evaluated as definitive (71.2%), 10 cases as probable (15.1%), and 9 cases as possible IgG4-RD (13.6%). 26 patients were diagnosed with GPA, 1 patient with localized GPA, 23 patients with MPA, and 4 patients with EGPA. The aorta, lacrimal tissue, pancreas, and retroperitoneum are the sites of IgG4-RD rather than AAV. AAV and IgG4-RD might coexist in the same patient. IgG4-RD is mainly associated with GPA.
Literatur
1.
Zurück zum Zitat Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Sumida T, Mimori T, Tanaka Y, Tsubota K, Yoshino T, Kawa S, Suzuki R, Takegami T, Tomosugi N, Kurose N, Ishigaki Y, Azumi A, Kojima M, Research Program for Intractable Disease by Ministry of Health, Labor and Welfare (MHLW) Japan G4 team (2010) A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Modern Rheumatol 22:1–14. https://doi.org/10.1007/s10165-011-0508-6CrossRef Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Sumida T, Mimori T, Tanaka Y, Tsubota K, Yoshino T, Kawa S, Suzuki R, Takegami T, Tomosugi N, Kurose N, Ishigaki Y, Azumi A, Kojima M, Research Program for Intractable Disease by Ministry of Health, Labor and Welfare (MHLW) Japan G4 team (2010) A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Modern Rheumatol 22:1–14. https://​doi.​org/​10.​1007/​s10165-011-0508-6CrossRef
3.
Zurück zum Zitat Boncoraglio MT, Prieto-González S, Fernandes-Serodio J, Corral-Molina JM, Solé M, Hernández-Rodríguez J (2021) Simultaneous presentation of granulomatosis with polyangiitis (GPA) and immunoglobulin G4-related disease (IgG4-RD). Leaving an open question: widening the spectrum of a single disease or real overlap? Modern Rheumatol Case Reports 5:108–112. https://doi.org/10.1080/24725625.2020.1782028CrossRef Boncoraglio MT, Prieto-González S, Fernandes-Serodio J, Corral-Molina JM, Solé M, Hernández-Rodríguez J (2021) Simultaneous presentation of granulomatosis with polyangiitis (GPA) and immunoglobulin G4-related disease (IgG4-RD). Leaving an open question: widening the spectrum of a single disease or real overlap? Modern Rheumatol Case Reports 5:108–112. https://​doi.​org/​10.​1080/​24725625.​2020.​1782028CrossRef
7.
Zurück zum Zitat Kawashima H, Utsugi A, Shibamiya A, Iida K, Mimura N, Ohashi H, Hase R, Kawakami M, Yanagisawa T, Hiraguri M (2019) Consideration concerning similarities and differences between ANCA-associated vasculitis and IgG-4-related diseases: case series and review of literature. Immunol Res 67:99–107. https://doi.org/10.1007/s12026-019-9070-7CrossRefPubMed Kawashima H, Utsugi A, Shibamiya A, Iida K, Mimura N, Ohashi H, Hase R, Kawakami M, Yanagisawa T, Hiraguri M (2019) Consideration concerning similarities and differences between ANCA-associated vasculitis and IgG-4-related diseases: case series and review of literature. Immunol Res 67:99–107. https://​doi.​org/​10.​1007/​s12026-019-9070-7CrossRefPubMed
17.
Zurück zum Zitat Wang GQ, Chen YP, Cheng H, Xu XY, Sun LJ, Dong HR (2019) Antineutrophil cytoplasmic antibody and/or antiglomerular basement membrane antibody associated crescentic glomerulonephritis in combination with IgG4-related tubulointerstitial nephritis. Clin Exp Rheumatol 37:279–285PubMed Wang GQ, Chen YP, Cheng H, Xu XY, Sun LJ, Dong HR (2019) Antineutrophil cytoplasmic antibody and/or antiglomerular basement membrane antibody associated crescentic glomerulonephritis in combination with IgG4-related tubulointerstitial nephritis. Clin Exp Rheumatol 37:279–285PubMed
21.
Zurück zum Zitat Danlos FX, Rossi GM, Blockmans D, Emmi G, Kronbichler A, Durupt S, Maynard C, Luca L, Garrouste C, Lioger B, Mourot-Cottet R, Dhote R, Arlet JB, Hanslik T, Rouvier P, Ebbo M, Puéchal X, Nochy D, Carlotti A, Mouthon L, French Vasculitis Study Group (2017) Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: a new overlap syndrome. Autoimmun Rev 16:1036–1043. https://doi.org/10.1016/j.autrev.2017.07.020CrossRefPubMed Danlos FX, Rossi GM, Blockmans D, Emmi G, Kronbichler A, Durupt S, Maynard C, Luca L, Garrouste C, Lioger B, Mourot-Cottet R, Dhote R, Arlet JB, Hanslik T, Rouvier P, Ebbo M, Puéchal X, Nochy D, Carlotti A, Mouthon L, French Vasculitis Study Group (2017) Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: a new overlap syndrome. Autoimmun Rev 16:1036–1043. https://​doi.​org/​10.​1016/​j.​autrev.​2017.​07.​020CrossRefPubMed
27.
Zurück zum Zitat Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Watts RA (2013) 2012 revised international chapel hill consensus conference nomenclature of Vasculitides. Arthritis Rheumatism 65:1–11. https://doi.org/10.1002/art.37715CrossRefPubMed Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Watts RA (2013) 2012 revised international chapel hill consensus conference nomenclature of Vasculitides. Arthritis Rheumatism 65:1–11. https://​doi.​org/​10.​1002/​art.​37715CrossRefPubMed
30.
Zurück zum Zitat Wallace ZS, Naden RP, Chari S, Choi HK, Della-Torre E, Dicaire JF, Hart PA, Inoue D, Kawano M, Khosroshahi A, Lanzillotta M, Okazaki K, Perugino CA, Sharma A, Saeki T, Schleinitz N, Takahashi N, Umehara H, Zen Y, Stone JH, Members of the ACR/EULAR IgG4-RD Classification Criteria Working Group (2020) The 2019 American college of rheumatology/European league against rheumatism classification criteria for IgG4-related disease. Annals Rheumatic Dis 79:77–87. https://doi.org/10.1136/annrheumdis-2019-216561CrossRef Wallace ZS, Naden RP, Chari S, Choi HK, Della-Torre E, Dicaire JF, Hart PA, Inoue D, Kawano M, Khosroshahi A, Lanzillotta M, Okazaki K, Perugino CA, Sharma A, Saeki T, Schleinitz N, Takahashi N, Umehara H, Zen Y, Stone JH, Members of the ACR/EULAR IgG4-RD Classification Criteria Working Group (2020) The 2019 American college of rheumatology/European league against rheumatism classification criteria for IgG4-related disease. Annals Rheumatic Dis 79:77–87. https://​doi.​org/​10.​1136/​annrheumdis-2019-216561CrossRef
33.
Zurück zum Zitat Grados A, Ebbo M, Piperoglou C, Groh M, Regent A, Samson M, Terrier B, Loundou A, Morel N, Audia S, Maurier F, Graveleau J, Hamidou M, Forestier A, Palat S, Bernit E, Bonotte B, Farnarier C, Harlé JR, Costedoat-Chalumeau N, Schleinitz N (2017) T Cell polarization toward TH2/TFH2 and TH17/TFH17 in patients with IgG4-related disease. Front Immunol 8:235. https://doi.org/10.3389/fimmu.2017.00235CrossRefPubMedPubMedCentral Grados A, Ebbo M, Piperoglou C, Groh M, Regent A, Samson M, Terrier B, Loundou A, Morel N, Audia S, Maurier F, Graveleau J, Hamidou M, Forestier A, Palat S, Bernit E, Bonotte B, Farnarier C, Harlé JR, Costedoat-Chalumeau N, Schleinitz N (2017) T Cell polarization toward TH2/TFH2 and TH17/TFH17 in patients with IgG4-related disease. Front Immunol 8:235. https://​doi.​org/​10.​3389/​fimmu.​2017.​00235CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Al-Soudi A, Doorenspleet ME, Esveldt RE, Burgemeister LT, Hak AE, van den Born BJH, Tas SW, van Vollenhoven RF, Klarenbeek PL, de Vries N (2019) IgG4:IgG RNA ratio differentiates active disease from remission in granulomatosis with polyangiitis: a new disease activity marker? A cross-sectional and longitudinal study. Arthritis Res Ther 21:43. https://doi.org/10.1186/s13075-018-1806-6CrossRefPubMedPubMedCentral Al-Soudi A, Doorenspleet ME, Esveldt RE, Burgemeister LT, Hak AE, van den Born BJH, Tas SW, van Vollenhoven RF, Klarenbeek PL, de Vries N (2019) IgG4:IgG RNA ratio differentiates active disease from remission in granulomatosis with polyangiitis: a new disease activity marker? A cross-sectional and longitudinal study. Arthritis Res Ther 21:43. https://​doi.​org/​10.​1186/​s13075-018-1806-6CrossRefPubMedPubMedCentral
Metadaten
Titel
Coexistence of IgG4-related disease and ANCA-associated vasculitis: case report and review of the literature
verfasst von
Cengiz Korkmaz
Reşit Yıldırım
Mustafa Dinler
Döndü U. Cansu
Publikationsdatum
27.08.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 3/2024
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-023-05419-x

Weitere Artikel der Ausgabe 3/2024

Rheumatology International 3/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

RAS-Blocker bei Hyperkaliämie möglichst nicht sofort absetzen

14.05.2024 Hyperkaliämie Nachrichten

Bei ausgeprägter Nierenfunktionsstörung steigen unter der Einnahme von Renin-Angiotensin-System(RAS)-Hemmstoffen nicht selten die Serumkaliumspiegel. Was in diesem Fall zu tun ist, erklärte Prof. Jürgen Floege beim diesjährigen Allgemeinmedizin-Update-Seminar.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.